• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺素E-1对周围动脉闭塞性疾病患者的影响。

Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.

作者信息

Milio G, Cospite V, Cospite M

机构信息

Unità Operativa Complessa di Angiologia, Azienda Ospedaliera Universitaria P. Giaccone, Università degli Studi di Palermo, Palermo, Italy.

出版信息

Minerva Cardioangiol. 2003 Jun;51(3):311-6.

PMID:12867883
Abstract

BACKGROUND

The purpose of the research is to determine the effects of PGE-1 in patients with chronic obliterans arteriopathy of the lower extremities and to investigate the possibility of its having an influence on local hemodynamics.

METHODS

The study comprises 123 patients aged between 39 and 75 years, suffering from Fontaine's Stage Two peripheral arteriopathy randomised into 2 therapeutic groups: the patients of Group 1 were treated with PGE-1, those of Group 2 with the association pentoxyfillin-buflomedil by venous infusion. The following were evaluated: the free walking distance on a treadmill; Rest Flow, Peak Flow and basal and minimum vascular resistance by means of strain gauge plethysmography; RF, PF, tPF and tRF by means of laserdoppler.

RESULTS

After 4 weeks of treatment an increase of 370% was observed in the absolute free walking distance and of 260% in that relative to patients treated with PGE-1, while the increase in the same parameters in Group 2 patients was considerably lower. Further, in Group 1 patients there was a significant increase in Peak Flow and an improvement in laserdoppler parameters markedly greater than those measured in the control group.

CONCLUSIONS

In conclusion, the data obtained point to the effectiveness of PGE-1 in patients suffering from Fontaine's Stage 2 obliterans arteriopathy: this substance in fact improves the microcirculation and leads to the development of collateral circuits with a consequent improvement in local hemodynamics and an increase in walking distance.

摘要

背景

本研究的目的是确定前列腺素E-1(PGE-1)对下肢慢性闭塞性动脉硬化患者的影响,并探讨其对局部血流动力学产生影响的可能性。

方法

该研究纳入了123例年龄在39至75岁之间、患有Fontaine二期周围动脉病变的患者,随机分为2个治疗组:第1组患者接受PGE-1治疗,第2组患者接受己酮可可碱-丁咯地尔联合静脉输注治疗。评估了以下指标:跑步机上的自由行走距离;通过应变片体积描记法测量的静息血流、峰值血流以及基础和最小血管阻力;通过激光多普勒测量的RF、PF、tPF和tRF。

结果

治疗4周后,观察到接受PGE-1治疗患者的绝对自由行走距离增加了370%,相对自由行走距离增加了260%,而第2组患者相同参数的增加幅度则低得多。此外,第1组患者的峰值血流显著增加,激光多普勒参数的改善明显大于对照组。

结论

总之,所获得的数据表明PGE-1对患有Fontaine二期闭塞性动脉硬化的患者有效:该物质实际上改善了微循环,并导致侧支循环的形成,从而改善了局部血流动力学并增加了行走距离。

相似文献

1
Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.前列腺素E-1对周围动脉闭塞性疾病患者的影响。
Minerva Cardioangiol. 2003 Jun;51(3):311-6.
2
The effects of prostaglandin E-1 in patients with intermittent claudication.前列腺素E-1对间歇性跛行患者的影响。
Cardiovasc Hematol Disord Drug Targets. 2006 Jun;6(2):71-6. doi: 10.2174/187152906777441812.
3
Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.在处于勒里什 - 方丹Ⅲ期的外周阻塞性动脉疾病患者中,伊洛前列素给药1周或4周后的临床及循环系统效应。
Eur Rev Med Pharmacol Sci. 1998 Mar-Apr;2(2):53-9.
4
Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.前列腺素E1治疗4周对间歇性跛行患者血浆内皮素-1释放的影响。
Int J Clin Pharmacol Ther. 1999 Jul;37(7):347-51.
5
Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.丙酰-L-肉碱用于勒里什-方丹二期外周动脉阻塞性疾病
Ann Vasc Surg. 2008 Jul-Aug;22(4):552-8. doi: 10.1016/j.avsg.2008.02.010. Epub 2008 May 27.
6
6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.银杏叶提取物与安慰剂针对外周动脉供血不足患者进行的双盲随机临床试验,两组平行对照,为期6个月。
Arzneimittelforschung. 1984;34(6):716-20.
7
Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).低密度脂蛋白单采术对周围动脉疾病患者的影响。周围动脉疾病低密度脂蛋白单采术多中心研究(P-LAS)。
Int Angiol. 2006 Sep;25(3):287-92.
8
Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.对患有勒里什II期闭塞性动脉病的糖尿病和非糖尿病患者,比较丙酰-L-肉碱与脉冲式肌肉按压疗效的评估。
Int Angiol. 2008 Jun;27(3):253-9.
9
Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
Minerva Cardioangiol. 2006 Jun;54(3):377-81.
10
[Conservative treatment of peripheral arterial occlusive diseases].[外周动脉闭塞性疾病的保守治疗]
Fortschr Med. 1978 Sep 14;96(34):1735-8.

引用本文的文献

1
Pentoxifylline for intermittent claudication.己酮可可碱用于间歇性跛行
Cochrane Database Syst Rev. 2020 Oct 16;10(10):CD005262. doi: 10.1002/14651858.CD005262.pub4.
2
Pentoxifylline for intermittent claudication.己酮可可碱用于间歇性跛行
Cochrane Database Syst Rev. 2015 Sep 29;9(9):CD005262. doi: 10.1002/14651858.CD005262.pub3.
3
Beneficial effects of intra-arterial and intravenous prostaglandin E1 in intestinal ischaemia-reperfusion injury.动脉内和静脉内注射前列腺素E1对肠道缺血再灌注损伤的有益作用。
Interact Cardiovasc Thorac Surg. 2014 Apr;18(4):466-74. doi: 10.1093/icvts/ivt552. Epub 2014 Jan 14.
4
Effect of prostaglandin E1 on ischemia-reperfusion injury during abdominal aortic aneurysm surgery.前列腺素E1对腹主动脉瘤手术期间缺血再灌注损伤的影响。
Surg Today. 2006;36(2):140-6. doi: 10.1007/s00595-005-3116-2.